Briggs Morrison, President, Head of R&D at Syndax Pharmaceuticals Inc (SNDX), sold 105,708 shares at $26.83 ($2.8M) on 2023-02-06, disclosed to the SEC on 2023-02-08.
Open-market sale of $2.8M SNDX by President, Head of R&D. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $26.83 | 52,854 | $1.4M | 50.0% |
| 2 | $26.83 | 52,854 | $1.4M | 50.0% |
| Total | $26.83 avg | 105,708 | $2.8M | 100% |
| Filing → |
| SNDX | SELL | 2023-08-10 | $1.9M | — | Filing → |
| SNDX | SELL | 2023-07-11 | $1.1M | — | Filing → |
| SNDX | SELL | 2023-06-09 | $2.2M | — | Filing → |